Subjects indicated for pacemaker, ICD, or CRT.
Conditions
Interventions
None listed
Sponsors
Medtronic Japan Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients indicated with and implated pacemaker, ICD, or CRT equipped with A-ATP therapy function. 2) Patients who understand and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients who cannot be set the device with the required A-ATP programming. 2) Patients with permanent Af. 3) Patients who cannot visit the hospital according to the follow-up schedule or who cannot collect the data through the CareLink system. 4) Patients who are unwilling to provide written informed consent. 5) Patients who are not anticipated to complete this study. 6) Patients who are limited to participate this study due to his/her medical condition.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A-ATP success rate on AT. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Prevalence of AT 2) Acceleration rate by A-ATP 3) Comparison of the prevalence of AT between patients with or without a history of AT. 4) Prevalence of AT in patients with pacemaker, ICD, or CRT. | — |
Countries
Japan
Contacts
Public ContactMasatsugu Okamoto
Medtronic Japan Co., Ltd. Clinical Affairs
Outcome results
None listed